New alliance through partnership agreement

OPHTEC signs agreement with VSA for Argentinian marketplace.

New alliance through partnership agreement
Colin Kerr
Colin Kerr
Published: Tuesday, July 9, 2019
OPHTEC BV has signed a partnership agreement with VSA to commercialise Ophtec’s products in the Argentinian marketplace. The Precizon™ IOL line as well as the Artisan® and Artiflex® line of Iris-Fixated Intraocular lenses are some of the products that will be commercialised by VSA. Teresa Filhó, Ophtec’s Export Manager, said: “Ophtec has a passion for vision and we look forward to continuing serving the Argentinian market and introducing our cataract lenses Precizon™.” Mauro Alvarez, sales director at VSA, noted: “I am proud to introduce this new alliance between VSA Alta Complejidad and Ophtec in Argentina: “It is undoubtedly a great opportunity to start working with such a prestigious company as Ophtec, which over its 35 years has remained faithful to his own ideas, always developing avant-garde concepts and products for the most demanding ophthalmologists.” https://www.ophtec.com/
Tags: partnership
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...